China Yongxin Pharmaceuticals Inc. completes reverse merger;
CHANGCHUN, China & LOS ANGELES---China Yongxin Pharmaceuticals Inc., a leading manufacturer, distributor and retailer of pharmaceuticals in Northeastern China, today announced that it has completed its previously announced reverse merger with Nutradyne Group, Inc. and, to better reflect the Company's true business, has changed its corporate name to China Yongxin Pharmaceuticals Inc. as well as its ticker symbol to ``OTCBB: CYXN.''
Medicis and LipoSonix, Inc. today jointly announced they have entered into a definitive merger agreement under which Medicis will acquire LipoSonix, an independent, privately-held company with a staff of approximately 40 scientists, engineers and clinicians located near Seattle, Washington.